Turn Therapeutics News and Activities

View the org chart displaying its 9 main executives

Most searched biographies at Turn Therapeutics

• Bradley Burnam, Chief Executive Officer and Founder
• Andrew Gengos, Board Director
• Kent Kester, Board Director

Popular executive movements at Turn Therapeutics

• Stephen Hahn has joined the company as Executive Clinical and Regulatory Lead  (posted on May 18 2026).
• Martin Dewhurst has joined the company as Board Member  (posted on January 9 2026).
• Andrew Scott has joined the company as Vice President of Corporate Communications  (posted on November 5 2025).

Click here to view some more movements at Turn Therapeutics

Create your alert
to follow the executive moves at Turn Therapeutics.

Turn Therapeutics has 3,498 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Turn Therapeutics

• Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model - Wed, 05/27/2026 - 08:05
• Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026 - Tue, 05/19/2026 - 08:01
• Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead - Mon, 05/18/2026 - 08:05
• Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates - Mon, 05/11/2026 - 16:05
• Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates - Tue, 03/31/2026 - 16:05
• Turn Therapeutics Secures Up to $25 Million in Financing From Avenue Capital Group - Tue, 03/24/2026 - 08:00
• Turn Therapeutics Appoints Dr. Robert Redfield as Senior Advisor of Health Policy and Regulatory Affairs - Tue, 02/17/2026 - 08:00
• Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences - Mon, 02/09/2026 - 08:00
• Events - Turn Therapeutics
• Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference - Mon, 01/12/2026 - 08:05
• View more press releases Close

Social media about Turn Therapeutics

• Turn Therapeutics on Wikipedia, Google News & Yahoo Finance
• Turn Therapeutics on LinkedIn, X (Twitter) & YouTube